NFE2L1 and Parkinson disease: This deficiency may be particularly damaging in the context of neurodegeneration, where neurons are already under oxidative stress due to mitochondrial dysfunction, inflammation, and age-related changes linking this with NFE2L1 dysfunctions may reveal new therapeutic potential in AD or PD.